Palliative percutaneous aortic valvuloplasty or replacement in the elderly: Saving Mrs. Ryan

Catheterization and Cardiovascular Interventions

Volumn 70, Issue 4, 2007, Pages 617-618

  Tan, Walter A ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA STENOSIS; AORTA VALVE REPLACEMENT; HEART FAILURE; HUMAN; MORBIDITY; NOTE; PATIENT CARE; QUALITY OF LIFE; RESTENOSIS; STROKE; TRANSLUMINAL VALVULOPLASTY; TREATMENT OUTCOME;

AGE FACTORS; AGING; AORTIC VALVE; AORTIC VALVE STENOSIS; BALLOON DILATATION; COMBINED MODALITY THERAPY; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PALLIATIVE CARE; PATIENT SELECTION; PROSTHESIS DESIGN; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 35348938613     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21344     Document Type: Note

References (9)

1. Murray SA, Kendall M, Boyd K, Sheikh A. Illness trajectories and palliative care. Br Med J 2005;330:1007-1011.
2. Pedersen WR, Klaassen PJ, Boisjolie CR, Pierce TA, Harris KM, Lesser JR, Hara H, Mooney MR, Graham KJ, Kshettry VR, Goldenberg IF, Priztker MR, Van Tassel RA, Schwartz RS. Feasibility of transcatheter intervention for severe aortic stenosis in patients ≥ 90 years of age: Aortic valvuloplasty revisited. Catheter Cardiovasc Interv 2007;70:151-156.
3. Berry C, Asgar A, Lamarche Y, Marcheix B, Couture P, Basmadjian A, Ducharme A, Laborde JC, Cartier R, Bonan R. Novel therapeutic aspects of percutaneous aortic valve replacement with the CoreValve Revalving System. Catheter Cardiovasc Interv 2007;70:610-616.
4. Otto CM, Mickel MC, Kennedy JW, et al., for the NHLBI Balloon Valvuloplasty Registry. Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis. Circulation 1984;89:642-650.
5. Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Nercolini D, Tapiero S, Litzler PY, Bessou J, Babaliaros V. Treatment of calcific aortic stenosis with the percutaneous heart valvemidterm follow-up from the initial feasibility studies: The French experience. J Am College Cardiol 2006;47:1214-1223.
6. Webb JG, Chandavimol M, Thompson CR, Ricci DR, Carere RG, Munt BI, Buller CE, Pasupati S, Lichtenstein S. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 2006;113:842-850.
7. Cribier A, Savin T, Saondi N, Rocha P, Berland J, Letac B. Balloon transluminal valvuloplasty of acquired aortic stenosis in elderly patients: An alternative to valve replacement? Lancet 1986;1:63-67.
8. Gunther S, Grossman W. Determinants of ventricular function in pressure-overload hypertrophy in man. Circulation 1979;59:679-688.
9. Safian RD, Warren SE, Berman AD, Diver DJ, McKay LL, Come PC, Grossman W, McKay RG. Improvement in symptoms and left ventricular performance after balloon aortic valvuloplasty in patients with aortic stenosis and depressed left ventricular ejection fraction. Circulation 1988;78:1181-1191.